Key result
This review outlines recent achievements and challenges in the development of a universal flu vaccine to provide broad and long-lasting immune protection against distinct influenza viruses.
Highlights the urgent need and current progress toward developing a universal influenza vaccine to provide broad, long-lasting immunity.
No change to current flu vaccination; leaves open optimization of broad-protection candidates.
Influenza is a global health concern. The single most effective way of protecting people against influenza infection and disease is vaccination. However, currently available vaccines against influenza induce only strain-specific immunity, and do not elicit long-lasting serum antibody titers. Therefore, they are ineffective in the case of possible pandemics. There is an urgent need for a new generation vaccine which would induce broad and long-lasting immune protection against antigenically distinct flu viruses. The paper presents recent achievements and the challenges in the field of universal vaccine construction.
No takes yet. Share an insight, caveat, or question.
Kęsik-Brodacka et al. (2014) conducted a review in Influenza. Universal flu vaccine was evaluated. This review outlines recent achievements and challenges in the development of a universal flu vaccine to provide broad and long-lasting immune protection against distinct influenza viruses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: